0001181431-13-015378.txt : 20130307
0001181431-13-015378.hdr.sgml : 20130307
20130307164934
ACCESSION NUMBER: 0001181431-13-015378
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130305
FILED AS OF DATE: 20130307
DATE AS OF CHANGE: 20130307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hamill John
CENTRAL INDEX KEY: 0001559058
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15313
FILM NUMBER: 13673990
MAIL ADDRESS:
STREET 1: 4092 NEW HOPE ROAD
CITY: FURLONG
STATE: PA
ZIP: 18925
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd373173.xml
HAMILL FORM 4
X0306
4
2013-03-05
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001559058
Hamill John
400 CROSSING BLVD
3RD FLOOR
BRIDGEWATER
NJ
08807
0
1
0
0
SVP, CFO
Common Stock
103613
D
Option to Purchase Common Stock
0.94
2013-03-05
4
A
0
110000
0
A
2023-03-05
Common Stock
110000
110000
D
These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
Philip K. Yachmetz as attorney-in-fact for John Hamill
2013-03-07